Phlomoides bracteosa
Phlomoides bracteosa · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Phlomoides bracteosa is a distinctive botanical species that has garnered significant interest within the field of pharmacological research. This plant is primarily recognized for its impressive biological activities, particularly its potent antimicrobial properties. Researchers are increasingly investigating its chemical constituents to understand how it combats various pathogenic microorganisms. By exploring these natural defense mechanisms, scientists hope to uncover new potential applications for traditional herbal remedies. Consequently, this species stands as a promising subject for developing future therapeutic treatments against infection.
- Synonyms
- Phlomis Bracteosa · Phlomoides Lamiifolia · 3 more
- Common names
- Not available
- Family
- Not available
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Phlomoides bracteosa is a striking plant recognized by several distinct names across different languages. In English-speaking regions, it is most commonly referred to as the Purple Mountain Torchwort. Similarly, it carries the Polish name żeleźniak purpurowy, reflecting its unique botanical identity. These various common names help gardeners and botanists alike identify its beautiful purple hues. Understanding these linguistic relationships is essential for anyone studying this specific species.
Sources: Catalogue of Life (COL)
Synonyms
Phlomoides bracteosa is a botanical subject characterized by a complex web of taxonomic synonyms. Scientific literature frequently identifies this species under the name Phlomis bracteosa. Its classification further extends to several distinct variations, including the labeled Phlomis bracteosa var. longifolia. Researchers also encounter this plant categorized as Phlomis cordata or Phlomis lamiifolia in various historical records. Additionally, the name Phlomis latifolia is recognized as another synonym tied to this specific plant's identity.
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Phlomoides bracteosa exhibits a broad geographic range that spans across diverse ecological zones in Asia. In the temperate regions, the species is found throughout Western Asia and Afghanistan. Moving into tropical climates, it is widely distributed across the Indian Subcontinent, including specific reaches of the East Himalaya and the West Himalaya. Its presence is also firmly established within the borders of Nepal and Pakistan. This extensive distribution highlights the plant's ability to thrive across varied mountainous and subtropical landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Phlomoides bracteosa is characterized by its distinct growth form as a herbaceous plant. This species remains entirely self-supporting as it develops within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Phlomoides bracteosa serves as a vital biological resource for the biomimetic synthesis of antimicrobial silver nanoparticles. By utilizing in vitro-derived plantlets, researchers can harness the plant's rich phenolic and flavonoid content to facilitate the reduction and capping of silver ions. This green synthesis method produces spherical nanoparticles that demonstrate significant bactericidal activity against various drug-resistant human pathogens. The high phytochemical potential of this endangered medicinal species makes it an ideal candidate for creating chemical-free nanomedicines. Consequently, the antimicrobial properties inherent in this plant's extracts offer promising advancements for diverse biomedical applications.
Compounds
Conditions
Phlomoides bracteosa serves as a vital biological agent in the biomimetic synthesis of antimicrobial silver nanoparticles. By utilizing the aqueous extract from in vitro-derived plantlets, researchers can leverage the plant's high phenolic and flavonoid content to reduce and cap silver ions. These resulting biogenic nanoparticles exhibit a characteristic spherical shape and uniform size optimized for medicinal use. Most significantly, these biosynthesized silver nanoparticles display enhanced bactericidal activity against multiple drug-resistant human pathogens. This relationship positions the plant as a key resource for developing effective nanomedicines to combat resistant infections.